Contact
RESOURCES
Global Point of Care
About Abbott

TOXICOLOGY

QUANTISAL™ II ORAL FLUID COLLECTION DEVICE

The best of Quantisal™ in a split specimen device.

The Quantisal™ II Oral Fluid Collection Device is the first commercially available oral fluid device with split specimen capabilities, offering the simplicity of collecting two samples with a single device that meets SAMHSA1 and DOT2 guidelines.

Contact Us
Quantisal™ Oral Fluid Collection Device
Benefits

Oral Fluid Benefits

  • Non-invasive, gender-neutral specimen collections
  • Collect samples anywhere
  • Observed collection protects from specimen tampering or adulteration
  • Excellent indication of recent drug use3
  • Parent drugs present in higher concentration than metabolites4
  • Easier implementation of random testing

Why Choose Quantisal™ II?

  • Meets SAMHSA and DOT Mandatory Guidelines for Federal Workplace
    Drug Testing Programs – Oral Fluid
  • Allows simultaneous collection of A and B specimens
  • Provides two 4 mL samples containing 1 mL of oral fluid and 3 mL of preservative
    buffer for adequate volume for screening and confirmation testing
  • Proprietary FDA 510(k) cleared device
HOW IT WORKS

How to collect a specimen: Quantisal™ II

infographic
Helpful Documents

Product Documents

Additional Resources

product-catalog

Learning xchange® Training

The Learning XChange® and training portal is your complete system for on-demand training. Our in-depth training portal ensures you and your organization perform testing in a manner consistent with manufacturer and industry recommendations.

Click here
product-catalog

INFORMATION GUIDES & RESOURCES

Click here to access the Abbott eLabeling website for electronic access to our user information guides, safety data sheets, product Instructions for Use (IFU) and more.

Global Point of Care eIFU

References

  1. Substance Abuse and Mental Health Services Administration (SAMHSA)
  2. Department of Transportation (DOT), Federal Aviation Administration, 14 CFR Part 120, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs, Federal Register Vol. 88 No. 84, May 02, 2023
  3. White, R, Moore, C. Detection of Drugs and Their Metabolites in Oral Fluid. Elsevier and RTI International, 2018.
  4. Dept of Health and Human Services (HHS) and Substance Abuse and Mental Health Services Administration (SAMHSA), Clinical Drug Testing in Primary Care. Technical Assistance Publication Series 32. HHS Publication 12-4668, 2012

INTENDED USE: The Quantisal™ II Oral Fluid Collection Device is intended for the collection, preservation and transportation of oral fluid specimens for drug of abuse testing. This device is for use only under observed collections.

A Leader in Toxicology

About Us
Our Solutions
Laboratory Drug Testing Services
Forensic Use Products
Products
Support
Interest-Based Ads
Contact Us
CONSUMER HEALTH DATA PRIVACY POLICY

©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.

Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy and Cookie Policy. HIPAA & Patient Info

Abbott - A Global Leader in Toxicology.